Navigation Links
United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals

United Kingdom is lagging in innovation, as shown by the market share of new medicines in various countries, including primary care and hospital markets. Reports from various sources prove that Europe has shown very low growth in the field of pharmaceuticals and hospital care//.

Europe has a new plan in order to counter the worsening competitive position of its biopharmaceutical enterprises. The policy is nominally based on a report submitted by Boston based international consultancy Charles River Associates (CRA) to the European Commission to investigate the status and reasons for Europe’s decline in Pharma industry.

Although the US market experienced similar landslides it has been able to grow to higher proportion in the field of new biologics. This is not happening in the case of Europe. “The decline is real and is likely to get worse,” noted independent biotech consultant David Glover, former research director of Cambridge Antibody Technology. Many young European firms, he said, are becoming disillusioned with the lack of reward for innovation.

European Commission Vice president Gunter Verheugen has announced a policy for referendum of the Europe’s biotech policy. The first aspect would be to double the financial support for life sciences research, taken from the six year, $132 billion Research Framework program that begins in 2007. The second aspect would be greasing the wheels of safety and efficacy testing for new types of medicines. The third policy would be to resolving a patchwork of different national systems for drug pricing, which” place a significant burden on industry and can delay access to the market.” The last policy of restricting on patients access to information on new medicines are to be considered.

Verheugen is confident that the program will deliver some concrete results within three years.

Source: Nature Biotechnoogy
'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. United Kingdom to perform its first Live Liver Transplant
4. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
5. United Kingdom: Farmers Cautioned To Plan Adequately For Bird-Flu
6. Bird-Flu Causes Alarm in United Kingdom.
7. 2010 AIDS Target May Misfire, Warns United Nations
8. AIDS Meet Ends Without Firm Commitments From Donors Dharam Shourie United Nations
9. United Nations draws flak Due to Lukewarm AIDS Prevention Measures
10. Chinese Poultry Smuggled into United States
11. United Kingdom: Making the most of sunshine without the cream

Post Your Comments:
(Date:11/8/2009)..., Critical legislation would strengthen Medicare...RK, Nov. 8 SUMMARY: Y...s passed critical health care reform legislation t...discrimination by insurance companies that prices ...erage. ,, The Affordable Health Care for Amer...
(Date:11/8/2009)...oring pain now can take you out of the game later,...ay News) -- Foot injuries are the talk of the NFL ...Eli Manning and running back Willie Parker. , O...tion and American Academy of Podiatric Sports Medi...et when they play fall sports like football and la...
(Date:11/8/2009)... 3D Global Solutions is plea...gram managing the proposal effort for ReSound who ...Digital Hearing Aid contract. The award includes n...Department of Defense and other federal agencies. ...vember 8, 2009 -- 3D Global Solutions is pleased t...
(Date:11/8/2009)..., "One victory does not mean the battle is won,"... 7 In a vote of 240-194...inski-Smith Amendment to prohibit abortion mandate.... ,, Americans United for Life Action President... this amendment is a victory for the pro-life Amer...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 T...Director, Operation Rescue Insurrecta Nex. ,, ...ry have been fighting to keep child-killing by abo..., Mr. Terry states: "This is a great first step to...t we have a lot of fighting ahead of us. Our rejoi...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...uspected SARS case in six months may have the coro... it was waiting for more results to come in.// ... contracted the SARS coronavirus," Xu Ruiheng, dep...g. A 32-year-old television worker is suspe...
... than 5 million service men and women before and a...reducing an alarmingly high rate of suicide seen a...had been particularly higher for black and white m...osocial problems, with an emphasis on removing the...
...elief that infants' brains don't divide into left-...tudy finds the brain's left hemisphere plays the l...s beginning almost immediately after birth. Re...ime fMRI has been used to study infants. It is a n...
...archers say common cold may help fight cancer. Re...neer the common cold virus so that //it kills canc... They did this by modifying one gene, so the virus.... Specialists say, “When the virus infects cells, ...
...hma have long recommended inhaled corticosteroid (... persistent forms of the condition.But reports abo...ple -- including parents of asthmatic children -- ...problems. Now leading scientists hope to put t...
...peutic option for patients with complicated type 1...e has been controversial. // Now, a new study f...pear to have worse survival than patients on the t... had or need a kidney transplant. However, in the ...
Other Medicine News:Health News:New Technique to Study Infants Brain. 2Health News:Benefits and Risks of Asthma Treatment Questioned 2Health News:Pancreas Transplant for Diabetics 2
(Date:11/6/2009)...all/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), ... of small-molecule therapeutics for the treatment ...HIV), today reported recent accomplishments and fi...ths ended September 30, 2009. ,, (Logo: http... ) ,, "Since our last quarterly update, we have...
(Date:11/6/2009)... Chimerix, Inc., a biopharmaceutic...erapeutics to address life-threatening diseases, p...,s lead antiviral compound, CMX001, to the World H...urity Initiative (GHSI). CMX001 is a broad-spectr...nt of smallpox, as well as other serious viral inf...
(Date:11/6/2009)...l/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX...biopharmaceutical company developing human vaccine...ency Virus) and other infectious agents, today ann...d provided an operational update. ,, Robert McN... commented, "We are pleased with our progress duri...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 1Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 2HIV Testing Day Set for Saturday in U S 50162 1Bausch 26 Lomb Kicks Off U S Consumer Online Marketing Campaign for SofLens 28R 29 Daily Disposable Contact Lenses 50158 1Bausch 26 Lomb Kicks Off U S Consumer Online Marketing Campaign for SofLens 28R 29 Daily Disposable Contact Lenses 50158 2
...n-Probe Incorporated,(Nasdaq: GPRO ) has submitte... supplemental regulatory application for the addit...reen donated blood for the hepatitis B,virus (HBV)...e assay to,screen donated blood for HIV-1 and the ...y is seeking approval to use the assay to screen f...
...1 Alfacell Corporation,(Nasdaq: ACEL ) today ann...,the 5th Cancer Drug Research & Development confer...ys impacted by ONCONASE stimulated,intracellular e... malignant,mesothelioma cell lines. Data presented...ll human cancer cells in cell culture and murine m...
Other Medicine Technology:Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 2Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 3Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 4Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 2Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 3
TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System
Wiseguide Guide Catheter
Convoy Catheter Introducer Sheaths
...-Cath, Maximum, Maximum Xtra, and Maximum ACT intr... specialty hemostasis introducers in the world. Th...ucers for use in interventional cardiology and ele...ngioplasty, stenting, atherectomy, temporary pacin...
Medicine Products: